Four-Month High-Dose Rifampicin Regimens for Pulmonary Tuberculosis.

Jindani, Amina; Atwine, Daniel; Grint, Daniel; Bah, Boubacar; Adams, Jack; Ticona, Eduardo Rómulo; Shrestha, Bhabana; Agizew, Tefera; Hamid, Saeed; Jamil, Bushra; +35 more... Byamukama, Adolf; Kananura, Keneth; Mugisha Taremwa, Ivan; Bonnet, Maryline; Camara, Lansana Mady; Bah-Sow, Oumou Younoussa; Bah, Kindy Sadio; Bah, Nene Mamata; Sow, Maimouna; Ticona Huaroto, César Eduardo; Mugruza Pineda, Raquel; Tandukar, Bijesh; Raya, Bijendra Bhakta; Shrestha, Neko; Mathoma, Anikie; Mathebula-Modongo, Unami P; Basotli, Joyce; Irfan, Muhammad; Begum, Dilshad; Muzammil, Ammara; Ahmed, Imran; Hasan, Rumina; Burgos, Marcos V; Sultan, Faisal; Hassan, Mariam; Masood, Iqra; Robb, Claire; Decker, Jonathan; Grubnic, Sisa; Butcher, Philip D; Witney, Adam; Dhillon, Jasvir; Munshi, Tulika; Fielding, Katherine; Harrison, Thomas S; (2023) Four-Month High-Dose Rifampicin Regimens for Pulmonary Tuberculosis. NEJM evidence, 2 (9). EVIDoa2300054-. ISSN 2766-5526 DOI: https://doi.org/10.1056/EVIDoa2300054

Additional Information

Item Type	Article
Faculty and Department	Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology & International Health (2023-)
PubMed ID	38320155
Elements ID	214850
Official URL	http://dx.doi.org/10.1056/evidoa2300054

Downloads

Accepted Version Download

Filename: Jindani-etal-2023-Four-month-high-dose-rifampicin .pdf

Description: This is an author accepted manuscript version of an article accepted for publication, and following peer review. Please be aware that minor differences may exist between this version and the final version if you wish to cite from it.

Licence: Creative Commons: Attribution-Noncommercial 4.0

Download